Why Medtronic Is One Of The Most Innovative Companies Of 2017

The $100 billion medical device maker Medtronic announced in September that it had received FDA approval for a new diabetes management system called the Mini­Med 670G. Developed initially for patients with type 1 diabetes, a condition typically diagnosed in children and young adults, the MiniMed consists of a wirelessly connected pump and glucose monitor that continuously track a user’s blood sugar levels and deliver insulin, reducing the need for finger pricks (users still have to recalibrate the device with a traditional finger-stick reading every 12 hours).